Cholestyramine, a proposed cholesterol lowering drug, was administered to 164 men for an average of seven years each. From Figure 20.1.
Cholestyramine, a proposed cholesterol lowering drug, was administered to 164 men for an average of seven years each. From Figure 20.1.